BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9520374)

  • 1. Anticancer action of cubé insecticide: correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities.
    Fang N; Casida JE
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3380-4. PubMed ID: 9520374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADH: ubiquinone oxidoreductase inhibitors block induction of ornithine decarboxylase activity in MCF-7 human breast cancer cells.
    Rowlands JC; Casida JE
    Pharmacol Toxicol; 1998 Nov; 83(5):214-9. PubMed ID: 9834970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cubé resin insecticide: identification and biological activity of 29 rotenoid constituents.
    Fang N; Casida JE
    J Agric Food Chem; 1999 May; 47(5):2130-6. PubMed ID: 10552508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous structure-activity relationships of 13-homo-13-oxarotenoids and 13-homo-13-oxadehyrorotenoids.
    Fang N; Rowlands JC; Casida JE
    Chem Res Toxicol; 1997 Aug; 10(8):853-8. PubMed ID: 9282833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent.
    Gerhauser C; Lee SK; Kosmeder JW; Moriarty RM; Hamel E; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 1997 Aug; 57(16):3429-35. PubMed ID: 9270009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insecticide target in the PSST subunit of complex I.
    Schuler F; Casida JE
    Pest Manag Sci; 2001 Oct; 57(10):932-40. PubMed ID: 11695186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotenone and rotenoids in cubè resins, formulations, and residues on olives.
    Cabizza M; Angioni A; Melis M; Cabras M; Tuberoso CV; Cabras P
    J Agric Food Chem; 2004 Jan; 52(2):288-93. PubMed ID: 14733510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
    Caboni P; Sherer TB; Zhang N; Taylor G; Na HM; Greenamyre JT; Casida JE
    Chem Res Toxicol; 2004 Nov; 17(11):1540-8. PubMed ID: 15540952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New bioactive flavonoids and stilbenes in cubé resin insecticide.
    Fang N; Casida JE
    J Nat Prod; 1999 Feb; 62(2):205-10. PubMed ID: 10075742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the inhibitory action of natural rotenone and its stereoisomers with various NADH-ubiquinone reductases.
    Ueno H; Miyoshi H; Ebisui K; Iwamura H
    Eur J Biochem; 1994 Oct; 225(1):411-7. PubMed ID: 7925463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes.
    Anderson WM; Delinck DL; Benninger L; Wood JM; Smiley ST; Chen LB
    Biochem Pharmacol; 1993 Feb; 45(3):691-6. PubMed ID: 8442768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial synthesis of novel and potent inhibitors of NADH:ubiquinone oxidoreductase.
    Nicolaou K; Pfefferkorn J; Schuler F; Roecker A; Cao G; Casida J
    Chem Biol; 2000 Dec; 7(12):979-92. PubMed ID: 11137820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPR characterization of ubisemiquinones and iron-sulfur cluster N2, central components of the energy coupling in the NADH-ubiquinone oxidoreductase (complex I) in situ.
    Magnitsky S; Toulokhonova L; Yano T; Sled VD; Hägerhäll C; Grivennikova VG; Burbaev DS; Vinogradov AD; Ohnishi T
    J Bioenerg Biomembr; 2002 Jun; 34(3):193-208. PubMed ID: 12171069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of complex I, rotenone-sensitive NADH: ubiquinone oxidoreductase, from the procyclic forms of Trypanosoma brucei.
    Fang J; Wang Y; Beattie DS
    Eur J Biochem; 2001 May; 268(10):3075-82. PubMed ID: 11358527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triton X-100 as a specific inhibitor of the mammalian NADH-ubiquinone oxidoreductase (Complex I).
    Ushakova AV; Grivennikova VG; Ohnishi T; Vinogradov AD
    Biochim Biophys Acta; 1999 Jan; 1409(3):143-53. PubMed ID: 9878712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second coenzyme Q1 binding site of bovine heart NADH: coenzyme Q oxidoreductase.
    Nakashima Y; Shinzawa-Itoh K; Watanabe K; Naoki K; Hano N; Yoshikawa S
    J Bioenerg Biomembr; 2002 Apr; 34(2):89-94. PubMed ID: 12018892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between mitochondrial NADH-ubiquinone oxidoreductase and ubiquinol-cytochrome c oxidoreductase. Evidence for stoicheiometric association.
    Ragan CI; Heron C
    Biochem J; 1978 Sep; 174(3):783-90. PubMed ID: 215122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural factors of rotenone required for inhibition of various NADH-ubiquinone oxidoreductases.
    Ueno H; Miyoshi H; Inoue M; Niidome Y; Iwamura H
    Biochim Biophys Acta; 1996 Sep; 1276(3):195-202. PubMed ID: 8856105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characterization of the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae.
    Velázquez I; Pardo JP
    Arch Biochem Biophys; 2001 May; 389(1):7-14. PubMed ID: 11370674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADH: ubiquinone oxidoreductase in obligate aerobic yeasts.
    Büschges R; Bahrenberg G; Zimmermann M; Wolf K
    Yeast; 1994 Apr; 10(4):475-9. PubMed ID: 7941733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.